Von Willebrand factor in plasma of patients with age related macular degeneration;Czynnik von Willebranda w osoczu chorych ze starczym zwyrodnieniem plamki

Klinika Oczna

Volumn 107, Issue 1-3, 2005, Pages 70-72

  Malukiewicz Wiśniewska, Grazyna ^a,b   Rość, Danuta ^a   Kałuzny, Bartłomiej ^a   Kałuzny, Jakub J ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b NONE   (Poland)

Author keywords

Age related macular degeneration; Hemostasis; Von Willebrand factor

Indexed keywords

ANTIBODY; VON WILLEBRAND FACTOR;

ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; RANK SUM TEST; RETINA MACULA AGE RELATED DEGENERATION; STATISTICAL ANALYSIS; AGED; BLOOD; CASE CONTROL STUDY; FEMALE; HOSPITALIZATION; MALE; METABOLISM; MIDDLE AGED; RETINA MACULA DEGENERATION;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; VON WILLEBRAND FACTOR;

EID: 24144434460     PISSN: 00232157     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Kagawa H., Okubo S., Yasunaga K.: Plasma coagulation and fibrinolysis in parameters in patients with collagen disease, and analysis of the multimeric structure of von Willebrand factor (vWF). Int. J. Hematol., 1991, 54, 429-439 .
2. Blann A. D.: Von Willebrand factor as an acute phase reactant and marker of endothelial cell injury in connective tissue diseases: a comparison with CRP, rheumathoid factor, and erythrocyte sedimentation rate. Zetisch. Rheumatologie, 1991, 50, 320-322.
3. Blann A. D., Dobrotowa M., Kubisz P., McCollum C. N.: Von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis. Thromb-Haemost., 1995, 74, 626-630.
4. Paczuski R., Białkowska A., Kotschy M., Burduk D., Betlejewski S.: Von Willebrand factor in plasma of patients with advanced stages of larynx cancer. Thromb. Res., 1999, 95, 197-200.
5. Paczuski R., Iwan-Zietek I., Bielawska J., Sadkiewicz S.: Von Willebrand factor in plasma of patients with rheumatoid arthritis and lupus erythematosus. Pol. Merk. Lek., 1998, 4, 254-255 .
6. Toschi V., Fiorini G. F., Motta A., Renoldi P., Paracchini M. L., Gibelli C.: Clinical significance of endothelial damage markers in essential mixed cryoglobulinemia. Acta Haematol., 1991, 86, 90-94.
7. Woodburn K. R., Rumlev A., Lowe G. D., Pollock J. G.: Fibrinogen and markers of fibrinolysis and endothelial damage following resolution of critical limb ischaemia. Eur. J. Vasc. Endovasc. Surg., 1995, 10, 272-278.
8. Van den Berg M., Boers G. H., Franken D. G., Blom H. J., Van kamp G. J., Jacobs C., Rauwerda J. A., Kluft C., Stehouwert C. D.: Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease. Eur. J. Clin. Invest., 1995, 25, 176-181.
9. Gadducci A., Baicchi U., Marrai R., del Bravo B., Fosella P. V., Facchini V.: Pretreatment plasma levels of fibrinopeptide-A (FFA), D-dimer (DD), and von Willebrand factor (vWf) in patients with ovarian carcinoma, Gynecol. Oncol., 1994, 53, 352-356.
10. Gadducci A., Baicchi U., Marrai R., Facchini V., del Bravo B., Fosella P. V., Fioretti P.: Pretreatment plasma levels of fibrinopeptide-A (FFA), D-dimer (DD), and von Willebrand factor (vWf) in patients with operable cervical cancer: influence of surgical-pathological stage, tumor size, histologic type, and lymph node status. Gynecol. Oncol., 1993, 49, 354-358.
11. Blann A. D., Herrick A., Jayson M. I.: Altered levels of soluble adhesion molecules in rheumatoid arthritis, vasculitis and systemic sclerosis. Br. J. Rheumatol., 1995, 34, 814-819.
12. Pottinger B. E., Read R. C., Paleolog E. M., Higgins P. G.: Von Willebrand factor is an acute phase reactant in man. Thromb. Res., 1989, 53, 387-394.
13. Lip P. L., Blann A. D., Hope-Ross M., Gibson J. M., Lip G. Y.: Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction. Ophthalmology, 2001, 108 (4), 705-710.
14. Abu-Zidan F. M., Farrant G., Zwi L. J., Simovic M. O., Day T., Bonham M. J., Windsor J. A.: Plasma von Willebrand factor and intestinal ischaemia-reperfusion injury in rats. Thromb. Res., 1999, 94, 353-358.